EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The Role of Pharmacovigilance Database in Identifying Antibiotic Resistance and Inappropriate Use: An Analysis of VigiBase Reports From Lower‐Middle‐Income Countries

Hager Saleh iD, Joseph Mitchell iD, Cecilia Stålsby Lundborg iD, Megha Sharma iD

Pharmacoepidemiology and Drug Safety · 2026

DOI: 10.1002/pds.70404 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pharmacoepidemiology and Drug Safety, 2026. Verfasst von Hager Saleh und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Global Public Health, Health Systems and Policy, Karolinska Institutet, Stockholm, Sweden. Hauptthemen laut MEDLINE: Pharmacovigilance, Anti-Bacterial Agents, Databases, Factual, Adverse Drug Reaction Reporting Systems. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Karolinska Institutet, Research Council of Norway, Norges Forskningsråd.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Digital databases such as pharmacovigilance (PV) databases could provide unique opportunities to monitor trends in suspected antibiotic resistance, ineffectiveness, and misuse, extending beyond their traditional role of tracking adverse drug reactions (ADRs). This approach is potentially valuable globally but particularly advantageous in lower‐middle‐income countries (LMICs) where formal resistance surveillance systems are often insufficiently developed. Leveraging PV data could help generate early signals of resistance and inappropriate antibiotic use and support antimicrobial stewardship in resource‐constrained settings.

Objectives

To explore the potential use of PV databases in monitoring suspected antibiotic resistance trends and inappropriate use in LMICs.

Methods

A retrospective cross‐sectional study was conducted using VigiBase. Data were extracted in October 2024 from inception to January 1, 2024. Reports involving antibacterials for systemic use, Anatomical Therapeutic Chemical (ATC) codes J01 and J04 from LMICs were included. Selected Medical Dictionary for Regulatory Activities (MedDRA) preferred terms were mapped according to RIOLE classification to the “resistance,” “ineffectiveness,” “off‐label use,” and “error” categories to identify reporting patterns. Descriptive statistics were used to summarize reports' characteristics, and associations between categorical variables were examined using chi‐squared tests.

Results

A total of 1570 ICSRs from 37 LMICs were identified, yielding 2958 drug–adverse event pairs, with reporting increasing markedly after 2016. The “off‐label use” (38.6%) and “ineffectiveness” (37.0%) were the dominant RIOLE categories, driven mainly by the preferred terms (PTs) of Off‐label use (795; 26.4%) and Drug ineffective (751; 25.4%). Resistance‐related PTs accounted for 12.7% of pairs, most frequently Drug resistance (210; 7.0%) and Pathogen resistance (132; 4.5%), while “error” category (11.7%) was led by Product use issue (60; 2.0%) and Medication error (44; 1.5%). Watch antibiotics predominated, especially azithromycin, ceftriaxone, and meropenem, with significant associations observed between RIOLE categories and age, reporter type, ATC class, reaction outcome, AWaRe category, and WHO region.

Conclusions

These findings demonstrate that PV databases can provide valuable insights into suspected antibiotic resistance and inappropriate use patterns in LMICs, supporting their potential role as additional data sources in antimicrobial stewardship.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PharmacovigilanceAnti-Bacterial AgentsDatabases, FactualAdverse Drug Reaction Reporting SystemsInappropriate PrescribingDrug Resistance, MicrobialHumansCross-Sectional StudiesRetrospective StudiesDeveloping CountriesAntimicrobial StewardshipResource-Limited SettingsDrug Resistance, Bacterial

Stichwörter der Autor:innen

AWaRe classificationMedDRARIOLEantibioticsantimicrobial resistancedrug ineffectivenessindividual case safety reportslower‐middle‐income countriesoff‐label usepharmacovigilance

Substanzen

Anti-Bacterial Agents

Autor:innen und Institutionen

  • Department of Global Public Health, Health Systems and Policy, Karolinska Institutet, Stockholm, Sweden.
  • Department of Pharmacology, Ruxmaniben Deepchand Gardi Medical College, Ujjain, India.

ORCID-Profile: Hager Saleh, Joseph Mitchell, Cecilia Stålsby Lundborg, Megha Sharma

Förderung

  • Karolinska Institutet
  • Research Council of Norway
  • Norges Forskningsråd

Zitieren

APA

Saleh, H., Mitchell, J., Lundborg, C. S., & Sharma, M. (2026). The Role of Pharmacovigilance Database in Identifying Antibiotic Resistance and Inappropriate Use: An Analysis of VigiBase Reports From Lower‐Middle‐Income Countries. Pharmacoepidemiology and Drug Safety. https://doi.org/10.1002/pds.70404

Vancouver

Saleh H, Mitchell J, Lundborg CS, Sharma M. The Role of Pharmacovigilance Database in Identifying Antibiotic Resistance and Inappropriate Use: An Analysis of VigiBase Reports From Lower‐Middle‐Income Countries. Pharmacoepidemiology and Drug Safety. 2026. doi:10.1002/pds.70404

BibTeX
@article{Saleh2026,
  author = {Saleh, Hager and Mitchell, Joseph and Lundborg, Cecilia Stålsby and Sharma, Megha},
  title = {The Role of Pharmacovigilance Database in Identifying Antibiotic Resistance and Inappropriate Use: An Analysis of VigiBase Reports From Lower‐Middle‐Income Countries},
  journal = {Pharmacoepidemiology and Drug Safety},
  year = {2026},
  doi = {10.1002/pds.70404}
}
Kostenlos starten →